Liu H - Search Results

1

Levothyroxine: Conventional and Novel Drug Delivery Formulations.

Liu H, Li W, Zhang W, Sun S, Chen C. Liu H, et al. Endocr Rev. 2023 May 8;44(3):393-416. doi: 10.1210/endrev/bnac030. Endocr Rev. 2023. PMID: 36412275 Free PMC article. Review.

2

Appraisal of radioiodine refractory thyroid cancer: advances and challenges.

Liu H, Yang D, Li L, Tu Y, Chen C, Sun S. Liu H, et al. Am J Cancer Res. 2020 Jul 1;10(7):1923-1936. eCollection 2020. Am J Cancer Res. 2020. PMID: 32774993 Free PMC article. Review.

3

The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis.

Liu H, Yang D, Chen X, Sun Z, Zou Y, Chen C, Sun S. Liu H, et al. Cancer Med. 2021 Feb;10(3):1043-1056. doi: 10.1002/cam4.3692. Epub 2020 Dec 31. Cancer Med. 2021. PMID: 33381923 Free PMC article.

4

Artificial Intelligence for Personalized Medicine in Thyroid Cancer: Current Status and Future Perspectives.

Li LR, Du B, Liu HQ, Chen C. Li LR, et al. Front Oncol. 2021 Feb 9;10:604051. doi: 10.3389/fonc.2020.604051. eCollection 2020. Front Oncol. 2021. PMID: 33634025 Free PMC article. Review.

5

Immune Checkpoint Inhibitors-Related Thyroid Dysfunction: Epidemiology, Clinical Presentation, Possible Pathogenesis, and Management.

Zhan L, Feng HF, Liu HQ, Guo LT, Chen C, Yao XL, Sun SR. Zhan L, et al. Front Endocrinol (Lausanne). 2021 Jun 10;12:649863. doi: 10.3389/fendo.2021.649863. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34177799 Free PMC article.

6

More Aggressive Cancer Behaviour in Thyroid Cancer Patients in the Post-COVID-19 Pandemic Era: A Retrospective Study.

Liu H, Zhan L, Guo L, Yu X, Li L, Feng H, Yang D, Xu Z, Tu Y, Chen C, Sun S. Liu H, et al. Int J Gen Med. 2021 Oct 27;14:7197-7206. doi: 10.2147/IJGM.S339998. eCollection 2021. Int J Gen Med. 2021. PMID: 34737615 Free PMC article.

7

Hypertension Was Associated with Higher Tumor Stages in Papillary Thyroid Cancer: A Large Sample Single-Center Study.

Li LR, Song JL, Liu HQ, Chen C. Li LR, et al. Metab Syndr Relat Disord. 2022 Oct;20(8):466-472. doi: 10.1089/met.2022.0033. Epub 2022 Sep 9. Metab Syndr Relat Disord. 2022. PMID: 36083278

8

Links between Breast and Thyroid Cancer: Hormones, Genetic Susceptibility and Medical Interventions.

Lu M, Liu H, Zheng B, Sun S, Chen C. Lu M, et al. Among authors: liu h. Cancers (Basel). 2022 Oct 19;14(20):5117. doi: 10.3390/cancers14205117. Cancers (Basel). 2022. PMID: 36291901 Free PMC article. Review.

9

Metabolic syndrome and thyroid Cancer: risk, prognosis, and mechanism.

Li LR, Song JL, Liu HQ, Chen C. Li LR, et al. Discov Oncol. 2023 Feb 22;14(1):23. doi: 10.1007/s12672-022-00599-7. Discov Oncol. 2023. PMID: 36811728 Free PMC article. Review.

10

Blood Profiles in the Prediction of Radioiodine Refractory Papillary Thyroid Cancer: A Case-Control Study.

Liu H, Chen Q, Liu B, Wang J, Chen C, Sun S. Liu H, et al. Among authors: liu b. J Multidiscip Healthc. 2023 Feb 27;16:535-546. doi: 10.2147/JMDH.S403045. eCollection 2023. J Multidiscip Healthc. 2023. PMID: 36879649 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97,125 results

Search Page

Filters